11 reports

The improving health infrastructure in Africa due to the growing prevalence of cancer, HIV/ AIDS, and genetic diseases is increasing the adoption of prenatal DNA sequencing in the continent.

  • Genetic Disorder
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Natera, Inc.

Gilead' s product portfolio and pipeline of investigational drugs encompasses treatments for HIV/ AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

  • Genetic Disorder
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Gilead' s product portfolio and pipeline of investigational drugs encompasses treatments for HIV/ AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

  • Genetic Disorder
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Engages in the development of drugs for HIV/ AIDS, liver diseases, hematology, oncology, cardiovascular, inflammation, respiratory, and other therapies.

  • Genetic Disorder
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Royalty Pharma Acquires Royalties on Cystic Fibrosis Treatments from Cystic Fibrosis Foundation Therapeutics for USD3.3 Billion

It offers its approved products in the therapeutic areas of rheumatoid arthritis (RA), Crohn' s disease, diabetes, chronic kidney disease, HIV/ AIDS and others.

  • Genetic Disorder
  • United States
  • Company Financials
  • M&A
  • RP Management LLC

In August 2004, National Institute of Allergy and Infectious Diseases (NIAID) registered a Phase IB/ IIA dose-finding safety and activity study to test the safety and anti-HIV activity of eight different doses of the HIV entry inhibitor AMD-## in HIV infected patien

  • Blood Supply
  • Genetic Disorder
  • Infectious Disease
  • Therapy
  • ADMA Biologics, Inc.
  • ROYALTY PHARMA ACQUIRES ROYALTIES ON CYSTIC FIBROSIS TREATMENTS FROM CYSTIC FIBROSIS FOUNDATION THERAPEUTICS FOR USD3.3 BILLION

It offers its approved products in the therapeutic areas of rheumatoid arthritis (RA), Crohn' s disease, diabetes, chronic kidney disease, HIV/ AIDS and others.

  • Cystic Fibrosis
  • Genetic Disorder
  • Pharmaceutical
  • Therapy
  • United States

The drug candidate was under development for the treatment of human immunodeficiency virus (HIV) Infections (AIDS).

  • Genetic Disorder
  • Infectious Disease
  • Therapy
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative

The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $## million and major research centers in HIV/ AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous bio

  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.
  • Clinical Trial profile. 188 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Genetic Disorder
  • Neurological Disorder
  • Therapy
  • World